The capital infusion positions Mirantus Health to capture a sizable, underserved segment of the eye‑care market, potentially reshaping preventive ophthalmology delivery and delivering strong returns for health‑tech investors.
Berlin‑based healthtech startup Mirantus Health announced a €5.5 million seed funding round. Backers include Revent, Redstone, Entrepreneur First, Noaber and Arve Capital, which will be used to broaden operations and reach underserved eye‑care markets.
Comments
Want to join the conversation?
Loading comments...